Vying Valves: Edwards’ Sapien Progresses, But CoreValve Remains A Threat

European data for Edwards Lifesciences' Sapien transcatheter heart valve are encouraging, but analysts have raised questions about design of the firm's planned U.S. trial of the device

More from Archive

More from Medtech Insight